Bioaffinity Technologies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.80

-0.03 (-3.18%)

As of Jun 29, 10:46 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,432.9% upside

Low Target $22.24

Average Target $28.39

High Target $33.42

Current Price $0.80

Current
$0.80

Target
$28.39

$22.24 $28.39 avg $33.42

Scenario Analysis

Bear Case

$22.24

2,667.5%

Low target

Base Case

$28.39

+3,432.9%

Avg target

Bull Case

$33.42

+4,058.8%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$13.80

-94.2% from high

52-Week Low

$0.69

+16.0% from low

Target vs 52W High

$28.39

+105.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%